Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Acadia Pharmaceuticals Inc. | ACAD

Daily Technical Analysis of Acadia Pharmaceuticals Inc.

There wasn't too much excitement in Acadia Pharmaceuticals today which only managed to move up 0.37% on the day.

It looks like Acadia Pharmaceuticals isn't currently at a very decisive point in regards to support/resistance levels. Acadia Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. ACAD may hit some resistance around the 17.79 level, more sellers may enter the market here and push price back down. But it's definitely not guaranteed.


Last analyzed on 2024-11-13

Analyst Ratings for Acadia Pharmaceuticals By Price Target And Rating

The analysts feel fairly neutral on the prospects for Acadia Pharmaceuticals but a little more positive than negative. The current Analysts Sentiment Score is 17.58. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Needham & Company LLC dropped their price target by -11.11% to $32.00 on 2024-03-12. Mizuho downgraded from Buy to Neutral on 2024-03-12 and decided to decrease their price target by -35.9% down to $25.00. JPMorgan Chase & Co. provided a price target decease of -9.38% to $29.00 from $32.00 on 2024-03-01. Royal Bank of Canada announced a lowering of their price target to $35.00 from $36.00 on 2024-02-28. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-02-28 and they set their price target at $42.00. On 2024-02-28 HC Wainwright reiterated their rating of Buy and added a price target of $33.00. JMP Securities reiterated a rating of Market Outperform on 2024-02-07 and added a price target of $42.00. Oppenheimer reiterated a rating of Market Perform on 2024-02-05 and added a price target of $25.00. Robert W. Baird announced that they are initiating coverage with a rating of Outperform on 2024-01-30 and provided a price target of $40.00. On 2023-12-19 Morgan Stanley upgraded Acadia Pharmaceuticals from Equal Weight to Overweight and moved up their price target to $40.00 which is a 29.03% increase.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
ACAD17.5825.77-5.9222.24-6.93

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-03-30)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
ACAD0.000.00

Short interest for Acadia Pharmaceuticals

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
ACAD4.44%4.592524.7-7.3267540000

How Acadia Pharmaceuticals compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
950.79-3.72-2.26-0.857.6740.0455.086.666.303.43-14013.76-12974.3016.844.749.368.41
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
2300.88-1.52-0.30-2.165.7227.6453.668.868.578.32-12704.99-11984.8218.914.246.745.55

Social Sentiment for Acadia Pharmaceuticals

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
ACAD

Companies with the highest correlation to Acadia Pharmaceuticals

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
XNCR | Xencor, Inc.0.860.380.9412.1040.02-0.1328.228316.107.187.98-4734.49-11116.170015.4823
DNLI | Denali Therapeutics Inc. 0.750.37-2.16-6.270.4527.5935.416974.38103.3059.38116.84-22833.860011.2371
SAGE | Sage Therapeutics, Inc0.690.00-8.57-37.45-37.85-56.63-74.6131-168.21-178.82-69.30-149709.64-1968.670012.6533
RCKT | Rocket Pharmaceuticals, I0.65-0.91-12.01-24.27-29.63-39.96-40.3729-88.38-65.83-77.27-23028.56-99.38009.12889

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-